These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 16004890)

  • 1. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
    Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
    Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
    Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
    G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin.
    Akdeniz B; Türker S; Oztürk V; Badak O; Okan T; Aslan O; Kozan O; Kirimli O; Aytekin D; Bariş N; Güneri S
    Int J Cardiol; 2005 Jan; 98(1):49-55. PubMed ID: 15676166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical role of flow velocity of left atrial auricle for prediction of short and long term success of cardioversion in patients with non-valvular atrial fibrillation].
    Pálinkás A; Varga A; Nyúzó B; Gruber N; Forster T; Nemes A; Horváth T; Fogas J; Boda K; Sepp R; Hógye M; Vass A; Csanády M
    Orv Hetil; 2002 Sep; 143(35):2035-41. PubMed ID: 12387197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events.
    Jung PH; Mueller M; Schuhmann C; Eickhoff M; Schneider P; Seemueller G; Dutton R; Rieber J; Kääb S; Sohn HY
    Cardiovasc Ultrasound; 2013 Jan; 11(1):1. PubMed ID: 23295101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
    Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation.
    Antonielli E; Pizzuti A; Pálinkás A; Tanga M; Gruber N; Michelassi C; Varga A; Bonzano A; Gandolfo N; Halmai L; Bassignana A; Imran MB; Delnevo F; Csanády M; Picano E
    J Am Coll Cardiol; 2002 May; 39(9):1443-9. PubMed ID: 11985905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
    Schädlich PK; Schmidt-Lucke C; Huppertz E; Lehmacher W; Nixdorff U; Stellbrink C; Brecht JG
    Am J Cardiovasc Drugs; 2007; 7(3):199-217. PubMed ID: 17610347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Goette A; Merino JL; Ezekowitz MD; Zamoryakhin D; Melino M; Jin J; Mercuri MF; Grosso MA; Fernandez V; Al-Saady N; Pelekh N; Merkely B; Zenin S; Kushnir M; Spinar J; Batushkin V; de Groot JR; Lip GY;
    Lancet; 2016 Oct; 388(10055):1995-2003. PubMed ID: 27590218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.